Eric T Fossel. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, CutaneousArginine/administration & dosageArginine/therapeutic useDiabetic Foot/drug therapyDiabetic Foot/physiopathologyDouble-Blind MethodFoot/blood supplyHumansNitric Oxide Synthase/metabolismNitric Oxide Synthase Type IIIRegional Blood Flow/drug effectsSkin Temperature/drug effects
Substances: See more » ArginineNOS3 protein, humanNitric Oxide SynthaseNitric Oxide Synthase Type III
Year: 2004 PMID: 14694013 DOI: 10.2337/diacare.27.1.284
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112